Healthcare - Biotechnology - NASDAQ - US
$ 54.72
-8.28 %
$ 5.07 B
Market Cap
-14.55
P/E
Price Target
Average
32.10%
Revenue Forecast
Estimate
237.23%
EBIT
Estimate
--23.57%
Net Income
Estimate
39.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Crinetics Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CRNX of $72.3 , with forecasts ranging from a low of $54 to a high of $97 .
CRNX Lowest Price Target
Wall Street Target
54 USD
-1.32%
CRNX Average Price Target
Wall Street Target
72.3 USD
32.10%
CRNX Highest Price Target
Wall Street Target
97 USD
77.27%
REVENUE FORECAST
Revenue Forecast Chart CRNX
EBIT FORECAST
EBIT Forecast Chart CRNX
NET INCOME FORECAST
Net Income Chart CRNX